NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of AUD 373.82 million. The enterprise value is 445.48 million.
| Market Cap | 373.82M |
| Enterprise Value | 445.48M |
Important Dates
The next estimated earnings date is Wednesday, January 28, 2026.
| Earnings Date | Jan 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 840.05 million shares outstanding. The number of shares has increased by 15.96% in one year.
| Current Share Class | 840.05M |
| Shares Outstanding | 840.05M |
| Shares Change (YoY) | +15.96% |
| Shares Change (QoQ) | +24.40% |
| Owned by Insiders (%) | 3.99% |
| Owned by Institutions (%) | 25.52% |
| Float | 642.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.32 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.41 |
| EV / Sales | 49.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.07 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.93 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.76 |
| Interest Coverage | -14.63 |
Financial Efficiency
Return on equity (ROE) is -43.89% and return on invested capital (ROIC) is -14.29%.
| Return on Equity (ROE) | -43.89% |
| Return on Assets (ROA) | -13.27% |
| Return on Invested Capital (ROIC) | -14.29% |
| Return on Capital Employed (ROCE) | -27.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.74 |
Taxes
In the past 12 months, NOVONIX has paid 149,002 in taxes.
| Income Tax | 149,002 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.37% in the last 52 weeks. The beta is 0.79, so NOVONIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -53.37% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 41.08 |
| Average Volume (20 Days) | 6,584,774 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NOVONIX had revenue of AUD 9.05 million and -101.05 million in losses. Loss per share was -0.18.
| Revenue | 9.05M |
| Gross Profit | 6.90M |
| Operating Income | -77.69M |
| Pretax Income | -100.90M |
| Net Income | -101.05M |
| EBITDA | -71.62M |
| EBIT | -77.69M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 37.86 million in cash and 109.52 million in debt, giving a net cash position of -71.66 million or -0.09 per share.
| Cash & Cash Equivalents | 37.86M |
| Total Debt | 109.52M |
| Net Cash | -71.66M |
| Net Cash Per Share | -0.09 |
| Equity (Book Value) | 219.38M |
| Book Value Per Share | 0.34 |
| Working Capital | -5.86M |
Cash Flow
In the last 12 months, operating cash flow was -61.80 million and capital expenditures -83.08 million, giving a free cash flow of -144.88 million.
| Operating Cash Flow | -61.80M |
| Capital Expenditures | -83.08M |
| Free Cash Flow | -144.88M |
| FCF Per Share | -0.17 |
Margins
| Gross Margin | 76.25% |
| Operating Margin | -858.71% |
| Pretax Margin | -1,115.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.96% |
| Shareholder Yield | -15.96% |
| Earnings Yield | -27.03% |
| FCF Yield | -38.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of -1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1 |
| Piotroski F-Score | 4 |